retatrutide phase 3 Diabetes Dialogue: Reduces Body Weight 28.7% in Trial Retatrutide: Phase 3 Results (Up

Hypersensitivity reactions including rash and urticaria are documented but uncommon

Transdermal delivery systems may additionally cause local skin reactions , including redness, itching, or irritation at the application site

This includes FDA-approved brand-name GLP-1 and GIP medications alongside nutritional coaching and educational resources

ABSTRACT: Objective: This systematic review aims to critically assess the literature on the mechanisms of action, clinical uses, formulation strategies, and adverse effects of self-tanning agents, with a focus on dihydroxyacetone (DHA), melanotan, forskolin, and carotenoids